U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H22N2O
Molecular Weight 246.348
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEPIVACAINE

SMILES

CN1CCCCC1C(=O)NC2=C(C)C=CC=C2C

InChI

InChIKey=INWLQCZOYSRPNW-UHFFFAOYSA-N
InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)

HIDE SMILES / InChI
Molecular Formula C15H22N2O
Molecular Weight 246.348
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:34:00 UTC 2023
Edited
by admin
on Fri Dec 15 16:34:00 UTC 2023
Record UNII
B6E06QE59J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MEPIVACAINE
INN   MI   VANDF   WHO-DD  
INN  
Official Name English
2-PIPERIDINECARBOXAMIDE, N-(2,6-DIMETHYLPHENYL)-1-METHYL-
Systematic Name English
MEPIVACAINE [VANDF]
Common Name English
(±)-MEPIVACAINE
Common Name English
CARBOPLYIN DENTAL
Brand Name English
MEPISV
Brand Name English
1-METHYL-2',6'-PIPECOLOXYLIDIDE
Common Name English
DL-MEPIVACAINE
Common Name English
(±)-1-METHYL-2',6'-PIPECOLOXYLIDIDE
Common Name English
Mepivacaine [WHO-DD]
Common Name English
N-(2,6-DIMETHYLPHENYL)-1-METHYL-2-PIPERIDINECARBOXAMIDE
Systematic Name English
2',6'-PIPECOLOXYLIDIDE, 1-METHYL-
Common Name English
TEVACAINE
Brand Name English
APF-135
Code English
SCANDICAINE
Brand Name English
2-PIPERIDINECARBOXAMIDE, N-(2,6-DIMETHYLPHENYL)-1-METHYL-, (±)-
Systematic Name English
mepivacaine [INN]
Common Name English
MEPIVACAINE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
WHO-ATC N01BB53
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
NDF-RT N0000007681
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
FDA ORPHAN DRUG 206705
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
NDF-RT N0000175682
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
WHO-VATC QN01BB03
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
CFR 21 CFR 522.1372
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
WHO-VATC QN01BB53
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
NDF-RT N0000175976
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
WHO-ATC N01BB03
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
FDA ORPHAN DRUG 206805
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
Code System Code Type Description
PUBCHEM
4062
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
LACTMED
Mepivacaine
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
RXCUI
6759
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY RxNorm
ECHA (EC/EINECS)
202-543-0
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
EPA CompTox
DTXSID9023259
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
NCI_THESAURUS
C61831
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
DRUG CENTRAL
1700
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
CHEBI
6759
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
INN
988
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
CAS
96-88-8
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
IUPHAR
7224
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
MESH
D008619
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
CAS
22801-44-1
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
SUPERSEDED
EVMPD
SUB14514MIG
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
WIKIPEDIA
MEPIVACAINE
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
DRUG BANK
DB00961
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
ChEMBL
CHEMBL1087
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
MERCK INDEX
m7196
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY Merck Index
SMS_ID
100000091383
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
FDA UNII
B6E06QE59J
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
DAILYMED
B6E06QE59J
Created by admin on Fri Dec 15 16:34:00 UTC 2023 , Edited by admin on Fri Dec 15 16:34:00 UTC 2023
PRIMARY
Related Record Type Details
Structure of MEPIVACAINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
Structure of DEXIVACAINE
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of 4'-HYDROXYMEPIVACAINE
METABOLITE -> PARENT
Related Record Type Details
Structure of MEPIVACAINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966